Efficacy of a tailored regimen of peginterferon α2b/ribavirin therapy for chronic hepatitis C, in which the treatment was maintained for 44 weeks after HCV RNA became undetectable at 5-24 weeks post initiation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.